Sign InSummary
Medical aesthetics company Sientra, Inc. (NASDAQ: SIEN) recently experienced a significant price change following FDA clearance for its AlloX2 Pro Tissue Expander, however, despite potential undervaluation, negative earnings and overbought state suggest a high level of risk, prompting analysts to categorize the stock as a Hold in their June 26, 2023 analysis.
Introduction
Sientra, Inc. (NASDAQ: SIEN) is a medical aesthetics company. The stock recently experienced a significant price change on the last close of $2.84 on June 26, 2023. In this analysis, we evaluate the stock based on technical and fundamental factors to determine whether it should be categorized as a Sell, Hold, or Buy.
Technical Analysis
SIEN experienced an 11.37% increase in price, closing at $2.84 on June 26, 2023. The stock traded between $2.45 and $2.92, which signals a high level of volatility for the stock. The RSI14 of 70 indicates that the stock is in overbought territory, suggesting that a price reversal might be imminent or is currently occurring. The stock is trading above its 50-day moving average ($1.73) and 200-day moving average ($2.64), indicating a positive trend. However, the MACD of 0.13 for the past three months suggests that the stock is overpriced, and investors should be cautious.
Fundamental Analysis
SIEN has a negative EPS of $-9.29 and a negative PE ratio of -0.31, reflecting poor earnings and a high risk for potential investors. The company has a market cap of $31.78 million and 11,189,200 outstanding shares. The average trading volume is 1.05 million, with a recent volume of 832,357.
Sientra recently received FDA clearance for its AlloX2 Pro Tissue Expander, causing the stock to skyrocket by 82.3% on heavy trading volume. Despite the positive news, the company's put/call ratio remains favorable, while short sellers are moving in as less bullish options are being observed. The discounted cash flow (DCF) model estimates a value of $6.47 for the stock, suggesting potential undervaluation.
Upcoming Price Prediction
Considering the technical and fundamental factors, we predict the following prices for SIEN:
- For the next trading day (June 27, 2023): The stock price could experience a minor pullback due to the overbought RSI14 and high volatility on the last trading day. Expect a trading range between $2.70 and $2.90.
- For the upcoming week: The stock could continue its positive trend, focusing on the $3.00 resistance level. Nevertheless, the overbought RSI14, potential short interest, and negative earnings should be considered when analyzing the stock's price movement.
Final Evaluation
In conclusion, despite the recent FDA clearance and positive trend, SIEN stock presents a high level of risk due to its negative earnings, overbought state, and potential short interest. While the discounted cash flow model suggests potential undervaluation, investors should weigh the risks and rewards carefully before making a decision.
Based on our analysis, we categorize SIEN as a Hold. While there is potential for short-term gains, the overall risk and volatility of the stock make it less suitable for long-term investments.
